Hyperion Therapeutics to Present at Needham's 12th Annual Healthcare Conference

Hyperion Therapeutics to Present at Needham's 12th Annual Healthcare
Conference

SOUTH SAN FRANCISCO, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- Hyperion
Therapeutics (Nasdaq:HPTX) announced today that the company is scheduled to
present at Needham's 12^th Annual Healthcare Conference on Tuesday, April 30
at 9:20 a.m. ET.

Donald J. Santel, Chief Executive Officer of Hyperion, will provide a company
overview. To access the live webcast and subsequent archived recording, please
visit Hyperion's website at http://investors.hyperiontx.com/events.cfm.

About Hyperion Therapeutics

Hyperion Therapeutics, Inc. is a commercial stage biopharmaceutical company
committed to developing and delivering life-changing treatments for orphan
diseases and hepatology.

CONTACT: Shari Annes, Investor Relations
         (650) 888-0902
         sannes@annesassociates.com
        
         Kristie Kuhl, Media Relations
         (203) 556-7417
         kkuhl@makovsky.com
 
Press spacebar to pause and continue. Press esc to stop.